Nuren Group Limited (NSX:NRN), Southeast Asia’s leading digital platform for women, has unveiled plans to pursue a listing on the Nasdaq Stock Exchange in the United States, signaling a major step in its global expansion strategy.
The move aims to provide Nuren with greater access to international capital, deepen institutional investor engagement, and elevate its profile on the global stage. The Group, whose digital brands include Motherhood.com.my, Ibuencer.com, and Kelabmama.com, currently serves more than 5 million users across Southeast Asia.
“This is more than just a listing – it’s a strategic leap forward in our mission to build Southeast Asia’s most trusted ecosystem for women, from marriage to motherhood,” said Petrina Goh, Group CEO of Nuren. “A Nasdaq listing enables us to amplify our purpose, engage with international capital markets, and unlock new levels of visibility, valuation, and trust.”
To facilitate the listing process, Nuren has appointed ZICO Evolve Capital Sdn Bhd as its financial adviser for IPO structuring and listing readiness. ZICO Evolve Capital – part of SGX-listed ZICO Holdings Inc. – will lead the advisory on capital markets strategy, financial structuring, and regulatory compliance, leveraging its cross-border expertise and regional presence.
“Nuren Group represents the kind of purposeful, high-growth company that resonates with global investors – particularly on Nasdaq,” said Chew Seng Kok, Executive Director of ZICO Evolve Capital. “We are pleased to work closely with their team to help unlock access to capital, international brand visibility, and a long-term roadmap for expansion.”
The Group recently launched its Motherhood Parenting SuperApp, an all-in-one digital platform offering pregnancy tracking, expert parenting content, access to healthcare resources, and a marketplace for family essentials. Positioned at the intersection of parenting, digital media, e-commerce, and women’s health, Nuren is poised to benefit from increasing global investor interest in female-focused tech platforms.
The proposed Nasdaq listing is expected to support Nuren’s goals for USD-denominated fundraising, potential cross-border acquisitions, and the formation of new strategic partnerships in healthcare and family-centric services.
“This step reflects not only where we are headed, but also who we aspire to become on the global stage,” added Petrina. “We remain committed to scaling with purpose, and this proposed listing marks a key milestone in that journey.”